LOSHITZER ZOHAR
Insider CIK 1280287 · ESWW Director · ACTC Director · LENS Chief Bus. Development Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LENS Presbia PLC | J Other | 2019-01-02 | 2019-01-04 | 72,464 | $3.45 | $250.0K | 72,464 | SEC↗ |
| LENS Presbia PLC | A Award | 2017-03-13 | 2017-04-14 | 12,738 | — | $0 | 378,960 | SEC↗ |
| LENS Presbia PLC | X Exercise deriv | 2017-03-08 | 2017-04-14 | 1,498 | — | $0 | 0 | SEC↗ |
| LENS Presbia PLC | X Exercise deriv | 2017-03-08 | 2017-04-14 | 1,999 | — | $0 | 0 | SEC↗ |
| LENS Presbia PLC | X Exercise deriv | 2017-03-08 | 2017-04-14 | 1,999 | — | $0 | 0 | SEC↗ |
| LENS Presbia PLC | X Exercise | 2017-03-08 | 2017-04-14 | 670 | $3.00 | $2.0K | 2,670 | SEC↗ |
| LENS Presbia PLC | X Exercise | 2017-03-08 | 2017-04-14 | 502 | $3.00 | $1.5K | 2,002 | SEC↗ |
| LENS Presbia PLC | X Exercise | 2017-03-08 | 2017-04-14 | 670 | $3.00 | $2.0K | 2,670 | SEC↗ |
| LENS Presbia PLC | X Exercise deriv | 2017-03-08 | 2017-03-10 | 2,742,639 | — | $0 | 0 | SEC↗ |
| LENS Presbia PLC | X Exercise | 2017-03-08 | 2017-03-10 | 91,959 | $3.00 | $275.9K | 371,722 | SEC↗ |
| LENS Presbia PLC | A Award | 2016-08-05 | 2016-08-09 | 8,247 | — | $0 | 279,763 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 5,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 834 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | U Tender | 2016-02-10 | 2016-02-11 | 21,834 | $8.50 | $185.6K | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award deriv | 2016-01-04 | 2016-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-12-31 | 2016-01-04 | 1,250 | — | $0 | 21,834 | SEC↗ |
| LENS Presbia PLC | P Buy | 2015-11-19 | 2015-11-23 | 2,000 | $4.00 | $8.0K | 271,516 | SEC↗ |
| LENS Presbia PLC | P Buy | 2015-11-19 | 2015-11-23 | 2,000 | $4.00 | $8.0K | 269,516 | SEC↗ |
| LENS Presbia PLC | P Buy | 2015-11-19 | 2015-11-23 | 1,500 | $4.00 | $6.0K | 267,516 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-09-30 | 2015-10-01 | 1,250 | — | $0 | 20,584 | SEC↗ |
| LENS Presbia PLC | J Other | 2015-08-03 | 2015-08-04 | 284,147 | — | $0 | 284,147 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-06-30 | 2015-07-02 | 1,250 | — | $0 | 19,334 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2015-03-31 | 2015-04-01 | 1,250 | — | $0 | 18,084 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award deriv | 2015-01-02 | 2015-01-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | A Award | 2014-12-31 | 2015-01-02 | 1,250 | — | $0 | 16,834 | SEC↗ |
| ESWW ENVIRONMENTAL SOLUTIONS WO | A Award | 2014-12-29 | 2014-12-30 | 250 | $80.00 | $20.0K | 1,241 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2014-09-30 | 2014-10-01 | 1,250 | — | $0 | 15,584 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2014-06-30 | 2014-07-02 | 125,000 | — | $0 | 1,433,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2014-03-31 | 2014-04-02 | 125,000 | — | $0 | 1,308,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2014-01-02 | 2014-01-03 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-12-31 | 2014-01-03 | 125,000 | — | $0 | 1,183,333 | SEC↗ |
| ESWW ENVIRONMENTAL SOLUTIONS WO | A Award | 2013-12-06 | 2013-12-09 | 396 | $30.00 | $11.9K | 991 | SEC↗ |
| ESWW ENVIRONMENTAL SOLUTIONS WO | A Award | 2013-12-06 | 2013-12-09 | 500 | $30.00 | $15.0K | 595 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-09-30 | 2013-10-02 | 125,000 | — | $0 | 1,058,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-06-28 | 2013-07-01 | 125,000 | — | $0 | 933,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-03-28 | 2013-04-01 | 125,000 | — | $0 | 808,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2013-01-02 | 2013-02-26 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-12-31 | 2013-01-04 | 125,000 | — | $0 | 683,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-09-28 | 2012-10-03 | 125,000 | — | $0 | 558,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-06-29 | 2012-07-16 | 125,000 | — | $0 | 433,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-03-30 | 2012-04-04 | 125,000 | — | $0 | 308,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2012-01-03 | 2012-08-09 | 500,000 | — | $0 | 500,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2011-11-14 | 2012-02-24 | 83,333 | — | $0 | 83,333 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2011-11-14 | 2012-02-24 | 183,333 | — | $0 | 183,333 | SEC↗ |